Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selonsertib in Diabetic Kidney Disease
NCT02177786Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of selonsertib in diabetic kidney disease (DKD), sponsored by Gilead Sciences. Started Jun 2014; status: completed.
02
Drugs
selonsertib
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT02177786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177786.